Immune-Guided drug timing could cut CMV risk after transplant
Prevention
Recruiting now
This study tests a personalized approach to prevent cytomegalovirus (CMV) infection in adults who have received a stem cell transplant. Instead of giving the prevention drug Letermovir for a fixed 100 days, doctors will use a blood test to check when the patient's own immune syst…
Phase: PHASE4 • Sponsor: WeiShi • Aim: Prevention
Last updated May 08, 2026 12:03 UTC